United States - English - NLM (National Library of Medicine)

msn laboratories private limited - dofetilide (unii: r4z9x1n2nd) (dofetilide - unii:r4z9x1n2nd) - maintenance of normal sinus rhythm (delay in af/afl recurrence) dofetilide capsules are indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [af/afl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. because dofetilide capsules can cause life threatening ventricular arrhythmias, it should be reserved for patients in whom atrial fibrillation/atrial flutter is highly symptomatic. in general, antiarrhythmic therapy for atrial fibrillation/atrial flutter aims to prolong the time in normal sinus rhythm. recurrence is expected in some patients (see clinical studies ). conversion of atrial fibrillation/flutter dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm. dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation. dofetilide is contraind

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - dapoxetine hydrochloride - tablets - 60

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - dapoxetine hydrochloride - tablets - 30 mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - nebivolol hydrochloride - tablets - 10mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - nebivolol hydrochloride - tablets - 2.5mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - nebivolol hydrochloride - tablets - 5mg

United States - English - NLM (National Library of Medicine)

msn laboratories private limited - trientine hydrochloride (unii: hc3nx54582) (trientine - unii:sj76y07h5f) - trientine hydrochloride capsules usp 250 mg is indicated in the treatment of patients with wilson's disease who are intolerant of penicillamine. clinical experience with trientine hydrochloride capsules usp 250 mg is limited and alternate dosing regimens have not been well-characterized; all endpoints in determining an individual patient's dose have not been well defined. trientine hydrochloride capsules usp 250 mg and penicillamine cannot be considered interchangeable. trientine hydrochloride capsules usp 250 mg should be used when continued treatment with penicillamine is no longer possible because of intolerable or life endangering side effects. unlike penicillamine, trientine hydrochloride capsules usp 250 mg is not recommended in cystinuria or rheumatoid arthritis. the absence ofa sulfhydryl moiety renders it incapable of binding cystine and, therefore, it is of no use in cystinuria. in 15 patients with rheumatoid arthritis, trientine hydrochloride capsules usp 250 mg was reported not to be effective i

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - clopidogrel - tablet, film-coated - 75 mg

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - montelukast sodium - tablets - -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

msn laboratories private limited , india - moxifloxacin - tablets - 400 mg